Granulocytic sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy.
Rosário Cavalheiro
Rita de Cássia
Rde C
Vicari
Perla
P
Maria Morselli
Fernanda
F
Ommati
Larissa Veloso M
LV
Frazão Rosa
Fanny de Oliveira
Fde O
Rodrigues Oliveira
José Salvador
JS
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000097:blood / Q000000981:diagnostic imaging / Q000628:therapy*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D011859:Radiography; D023981:Sarcoma, Myeloid / Q000000981:diagnostic imaging / Q000628:therapy*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate